Search Results: Securities Litigation


Webinar: 2022-2023 Key Trends and Updates: Securities Litigation Against Life Sciences Companies

Publicly traded life sciences companies continue to be the primary target of the plaintiffs’ bar, facing far more securities class action lawsuits compared to other sectors. What does this mean for your business, and what practical steps can you take to make informed choices? Join Caroline Bullerjahn, Courtney Orazio, and…

Read More

2020 Year in Review: Securities Litigation Against Life Sciences and Healthcare Companies

Despite the turmoil and disruption of 2020, plaintiffs’ lawyers and courts appear to have adapted readily to our “new normal.” Although at lower rates than previous years, plaintiffs’ firms continued to file securities class actions against publicly traded pharmaceutical, biotechnology, medical device and healthcare product and services companies in 2020,…

Read More